Screening a protein kinase inhibitor library against Plasmodium falciparum

Abstract Background Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malari...

Full description

Bibliographic Details
Main Authors: Irene Hallyburton, Raffaella Grimaldi, Andrew Woodland, Beatriz Baragaña, Torsten Luksch, Daniel Spinks, Daniel James, Didier Leroy, David Waterson, Alan H. Fairlamb, Paul G. Wyatt, Ian H. Gilbert, Julie A. Frearson
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Malaria Journal
Online Access:http://link.springer.com/article/10.1186/s12936-017-2085-4
_version_ 1811236629523726336
author Irene Hallyburton
Raffaella Grimaldi
Andrew Woodland
Beatriz Baragaña
Torsten Luksch
Daniel Spinks
Daniel James
Didier Leroy
David Waterson
Alan H. Fairlamb
Paul G. Wyatt
Ian H. Gilbert
Julie A. Frearson
author_facet Irene Hallyburton
Raffaella Grimaldi
Andrew Woodland
Beatriz Baragaña
Torsten Luksch
Daniel Spinks
Daniel James
Didier Leroy
David Waterson
Alan H. Fairlamb
Paul G. Wyatt
Ian H. Gilbert
Julie A. Frearson
author_sort Irene Hallyburton
collection DOAJ
description Abstract Background Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malaria is still being investigated. Therefore, rather than assaying against individual protein kinases, a library of 4731 compounds with protein kinase inhibitor-like scaffolds was screened against the causative parasite, Plasmodium falciparum. This approach is more holistic and considers the whole kinome, making it possible to identify compounds that inhibit more than one P. falciparum protein kinase, or indeed other malaria targets. Results As a result of this screen, 9 active compound series were identified; further validation was carried out on 4 of these series, with 3 being progressed into hits to lead chemistry. The detailed evaluation of one of these series is described. Discussion This screening approach proved to be an effective way to identify series for further optimisation against malaria. Compound optimisation was carried out in the absence of knowledge of the molecular target. Some of the series had to be halted for various reasons. Mode of action studies to find the molecular target may be useful when problems prevent further chemical optimisation. Conclusions Progressible series were identified through phenotypic screening of a relatively small focused kinase scaffold chemical library.
first_indexed 2024-04-12T12:12:22Z
format Article
id doaj.art-566b9ef7b74a4082b406a4a2a9e0d020
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-04-12T12:12:22Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-566b9ef7b74a4082b406a4a2a9e0d0202022-12-22T03:33:33ZengBMCMalaria Journal1475-28752017-11-0116111110.1186/s12936-017-2085-4Screening a protein kinase inhibitor library against Plasmodium falciparumIrene Hallyburton0Raffaella Grimaldi1Andrew Woodland2Beatriz Baragaña3Torsten Luksch4Daniel Spinks5Daniel James6Didier Leroy7David Waterson8Alan H. Fairlamb9Paul G. Wyatt10Ian H. Gilbert11Julie A. Frearson12Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeMedicines for Malaria VentureMedicines for Malaria VentureDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeDrug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of DundeeAbstract Background Protein kinases have been shown to be key drug targets, especially in the area of oncology. It is of interest to explore the possibilities of protein kinases as a potential target class in Plasmodium spp., the causative agents of malaria. However, protein kinase biology in malaria is still being investigated. Therefore, rather than assaying against individual protein kinases, a library of 4731 compounds with protein kinase inhibitor-like scaffolds was screened against the causative parasite, Plasmodium falciparum. This approach is more holistic and considers the whole kinome, making it possible to identify compounds that inhibit more than one P. falciparum protein kinase, or indeed other malaria targets. Results As a result of this screen, 9 active compound series were identified; further validation was carried out on 4 of these series, with 3 being progressed into hits to lead chemistry. The detailed evaluation of one of these series is described. Discussion This screening approach proved to be an effective way to identify series for further optimisation against malaria. Compound optimisation was carried out in the absence of knowledge of the molecular target. Some of the series had to be halted for various reasons. Mode of action studies to find the molecular target may be useful when problems prevent further chemical optimisation. Conclusions Progressible series were identified through phenotypic screening of a relatively small focused kinase scaffold chemical library.http://link.springer.com/article/10.1186/s12936-017-2085-4
spellingShingle Irene Hallyburton
Raffaella Grimaldi
Andrew Woodland
Beatriz Baragaña
Torsten Luksch
Daniel Spinks
Daniel James
Didier Leroy
David Waterson
Alan H. Fairlamb
Paul G. Wyatt
Ian H. Gilbert
Julie A. Frearson
Screening a protein kinase inhibitor library against Plasmodium falciparum
Malaria Journal
title Screening a protein kinase inhibitor library against Plasmodium falciparum
title_full Screening a protein kinase inhibitor library against Plasmodium falciparum
title_fullStr Screening a protein kinase inhibitor library against Plasmodium falciparum
title_full_unstemmed Screening a protein kinase inhibitor library against Plasmodium falciparum
title_short Screening a protein kinase inhibitor library against Plasmodium falciparum
title_sort screening a protein kinase inhibitor library against plasmodium falciparum
url http://link.springer.com/article/10.1186/s12936-017-2085-4
work_keys_str_mv AT irenehallyburton screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT raffaellagrimaldi screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT andrewwoodland screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT beatrizbaragana screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT torstenluksch screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT danielspinks screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT danieljames screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT didierleroy screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT davidwaterson screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT alanhfairlamb screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT paulgwyatt screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT ianhgilbert screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum
AT julieafrearson screeningaproteinkinaseinhibitorlibraryagainstplasmodiumfalciparum